Home Altamira Therapeutics

Altamira Therapeutics

In operation
IPO
Developer of Allergy, Viral Infection, and RNA Therapies

Basic Information

Altamira Therapeutics is dedicated to developing treatments to address unmet medical needs. It is active in RNA therapeutics, allergies and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows therapeutic RNAs to complex with proprietary peptides to form nanoparticle formulations. This formulation enables the delivery of therapeutic RNA to tissues affected by leaky blood vessels through systemic administration, a hallmark of solid tumors and certain inflammatory conditions.
Altamira Therapeutics
Bermuda,British Overseas Territories,United Kingdom
15~50 people
April 01, 2003
hear@altamiratherapeutics.com